Compatibility of budesonide inhalation suspension with four nebulizing solutions

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 967-972

  McKenzie, Jane E ^a   Cruz Rivera, Mario ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Albuterol; Asthma; Budesonide inhalation suspension

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; LEVALBUTEROL; SALBUTAMOL SULFATE;

ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE CONTROL; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG MIXTURE; DRUG SOLUTION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NEBULIZER; PH; PRECIPITATION; PRIORITY JOURNAL; RECORDING; STANDARD; SUSPENSION; SYMPTOM; VALIDATION PROCESS;

ANTI-ASTHMATIC AGENTS; BRONCHODILATOR AGENTS; BUDESONIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INCOMPATIBILITY; NEBULIZERS AND VAPORIZERS; SUSPENSIONS;

EID: 2442637914     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D335     Document Type: Article

References (22)

1. Pediatric asthma: a growing health threat. American Lung Association. www.lungusa.org/asthma/merck_pediatric.html (accessed 2001 Dec 28).
2. Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon LL, Johnson CA, et al. Surveillance for asthma-United States, 1960-1995. MMWR CDC Surveill Summ 1998;47:1-27.
3. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma. Update on selected topics-2002. J Allergy Clin Immunol 2002;110(5 suppl):S141-219.
4. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
5. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled in patients with mild asthma. N Engl J Med 1994;331:700-5.
6. Overbeek SE, Kerstjens HAM, Bogaard JM, Mulder PGH, Postma DS, and the Dutch CNSLD Study Group. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? Chest 1996;110:35-41.
7. Selroos O, Pietinalho A, Löfroos A-B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
8. Bush A. Asthma in the child under five. Br J Hosp Med 1996;55:110-4.
9. Szefler SJ. Clinical need for a nebulized corticosteroid. J Allergy Clin Immunol 1999;104(4 pt 2):162-8.
10. Baker JW, Mellon M, Wald J, Welch M, Cruz-Rivera M, Walton-Bowen K. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 1999;103:414-21.
11. Kemp JP, Skoner DP, Szefler SJ, Walton-Bowen K, Cruz-Rivera M, Smith JA. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol 1999;83:231-9.
12. Shapiro G, Mendelson L, Kraemer MJ, Cruz-Rivera M, Walton-Bowen K, Smith JA. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 1998;102:789-96.
13. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1997; NIH publication no. 97-4051.
14. Reid A, Murphy C, Steen HJ, McGovern V, Shields MD. Linear growth of very young asthmatic children treated with high-dose nebulized budesonide. Acta Paediatr 1996;85:421-4.
15. Sano F, Cortez GK, Solé D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J Allergy Clin Immunol 2000;105:669-703.
16. Lesko LJ, Miller AK. Physical-chemical compatibility of cromolyn sodium nebulizer solution-bronchodilator inhalant solution admixtures. Ann Allergy 1984;53:236-8.
17. Emm T, Metcalf JE, Lesko LJ, Chai MF. Update on the physical-chemical compatibility of cromolyn sodium nebulizer solution: bronchodilator inhalant solution admixtures. Ann Allergy 1991;66:185-9.
18. Roberts GW, Rossi SOP. Compatibility of nebuliser solutions. Aust J Hosp Pharm 1993;23:35-7.
19. Grönberg S, Magnusson P, Bladh N. Chemical compatibility of budesonide inhalation suspension (Pulmicort Respules) with other nebulization products (abstract). Am J Respir Crit Care Med 2001;163:A588.
20. Smaldone GC, McKenzie J, Cruz-Rivera M. Effect of nebulizer volume on drug delivery: budesonide inhalation suspension (abstract). Am J Respir Crit Care Med 2000;161:A36.
21. Trissel LA. Handbook on injectable drugs. 10th ed. Bethesda, MD: American Society of Health-System Pharmacists, 1998:vi-ix.
22. McKenzie J, Grönberg S, Cruz-Rivera M, Hoag JE. Budesonide inhalation suspension can be nebulized with solutions containing albuterol sulfate (abstract). Chest 2002;122(suppl):183S.